title: Use of implantable cardioverter-defibrillators in the congenital long QT syndrome.
abstract: We surveyed the use of implantable cardioverter-defibrillators in patients with congenital long QT syndrome. The implantable cardioverter-defibrillator was used primarily in high-risk persons and appeared safe and effective over a mean 31-month follow-up.
authors.affiliation: Department of Medicine (Cardiology), Oregon Health Sciences University, Portland 97201-3098, USA.
authors.forename: W J
authors.initials: WJ
authors.lastname: Groh
authors.forename: M J
authors.initials: MJ
authors.lastname: Silka
authors.forename: R P
authors.initials: RP
authors.lastname: Oliver
authors.forename: B D
authors.initials: BD
authors.lastname: Halperin
authors.forename: J H
authors.initials: JH
authors.lastname: McAnulty
authors.forename: J
authors.initials: J
authors.lastname: Kron
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D017147:Defibrillators, Implantable; D005260:Female; D006801:Humans; D007223:Infant; D008133:Long QT Syndrome / Q000151:congenital / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome